Law360, New York (December 16, 2010, 2:10 PM ET) -- Federal prosecutors are standing by their argument that an executive of drugmaker InterMune Inc. should go to prison for 10 years for fraudulently marketing one of the company's products for a deadly lung disease it was not approved to treat.
According to a new sentencing memorandum filed Wednesday in the U.S. District Court for the Northern District of California, prosecutors' initial $20 million loss calculation is accurate, yielding a 10-year prison term for Dr. W. Scott Harkonen, but they offered Judge Marilyn Patel four alternate ways...
Feds Defend 10-Year Sentence For InterMune Exec
To view the full article, take a free trial now.
